Ambiq Micro, Inc.
NYSE:AMBQSemiconductors
+$5.10 today
- Market cap
- $1.13B
- Beta
- 5.68
- P/E (TTM)
- -44.8
- EPS (TTM)
- -$1.88
Volume 0.45M
Average 0.58M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Ambiq Micro, Inc.
NYSE:AMBQ
Intrinsic Alpha fair value
Locked
Current Price
$45.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | -7.3% | +30.3% (4yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at -7.3% over three years. Forward estimates point to Revenue at +30.3% (4yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
AXT, Inc. NASDAQ:AXTI | $2.74B | $41.84 | Not rated | -338.5 | +267.88% |
Wolfspeed, Inc. NYSE:WOLF | $1.33B | $24.83 | Not rated | -1.8 | +31.61% |
Arteris, Inc. NASDAQ:AIP | $960.37M | $19.34 | Overvalued | -57.4 | +41.22% |
POET Technologies Inc. NASDAQ:POET | $677.23M | $5.13 | Not rated | -21.7 | +2.56% |
Weave Communications, Inc. NYSE:WEAV | $595.33M | $7.40 | Overvalued | -16.4 | +27.37% |
Backblaze, Inc. NASDAQ:BLZE | $489.17M | $7.74 | Overvalued | -21.2 | +51.65% |
Cerence Inc. NASDAQ:CRNC | $358.22M | $7.92 | Undervalued | -23.5 | -8.82% |
Domo, Inc. NASDAQ:DOMO | $155.39M | $3.55 | Overvalued | -1.9 | -69.08% |
NovaBridge Biosciences NASDAQ:NBP | $42.59M | $0.85 | Not rated | -25.5 | -81.89% |
Blaize Holdings, Inc. NASDAQ:BZAI | $23.23M | $0.16 | Not rated | -2.1 | -81.05% |
Continue the stock analysis
Jump to another research area for this company.